Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 55)
10 November 2025
RWE Wins Two Onshore Wind Projects in France
RWE secures two wind projects in France, totaling 21.6 MW, contributing to its regional growth and energy transition efforts.
10 November 2025
RWE Installs Recyclable Blades, Over Half of Turbines at Sofia Offshore Wind Farm
Sofia Offshore Wind Farm progresses with 60% of turbines installed. Recyclable blades mark UK's first large-scale deployment, aiming for full operation by September 2026.
10 November 2025
TCO Showcases Engineering Expertise in Atyrau
The Atyrau roundtable focused on engineering advancements, local integration, and safety in Kazakhstan's oil and gas sector, highlighting innovative projects and skill development.
10 November 2025
Roche's Fenebrutinib Shows Promising Phase III Results for Multiple Sclerosis
Fenebrutinib reduces relapses in RMS and slows disability in PPMS, showing potential as a high-efficacy oral treatment. Full data expected by 2026 for regulatory submission.
9 November 2025
Merck's Enlicitide Decanoate Cuts LDL-C in HeFH Patients in Phase 3 Trial
Enlicitide decanoate shows significant LDL-C reduction in HeFH patients, with a safety profile similar to placebo, in the CORALreef HeFH trial.
7 November 2025
LOTTE Chemical Completes Indonesian Petrochemical Complex, Expands in Southeast Asia
The new complex boosts Indonesia's petrochemical self-sufficiency to 90%, enhances local economy, and integrates with existing facilities for cost efficiency.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
7 November 2025
Takeda's Mezagitamab Maintains Kidney Function in IgAN After 18 Months
Mezagitamab shows stable eGFR, reduced proteinuria, and no serious adverse events in IgAN patients 18 months post-treatment; Phase 3 trials are underway.
7 November 2025
EnviTec Biogas Launches First Philippine Plant
A 1.4 MW biogas plant in the Philippines will convert poultry manure into power and bio-fertilizer, feeding electricity into the local grid by June 2026. Expansion plans are underway.
7 November 2025
RWE Completes Wind Turbine Foundations for Nordseecluster A
Nordseecluster A's 44 turbine foundations are installed. The project will generate 660 MW by 2027, with Nordseecluster B adding 900 MW by 2029, powering 1.6 million German homes.
7 November 2025
MOL Group Revises 2025 EBITDA Guidance Amid Strong Q3 Results
Q3 profit stable at USD 503 mn. Upstream steady, downstream boosted by refining margins. Consumer Services grew, Circular Economy Services faced seasonal challenges. Guidance reviewed.
7 November 2025
ORLEN Group Completes Seabed Surveys for Offshore Wind Farm
Seabed surveys in the Baltic East project area were completed, enabling the next project stages. Data will aid in geological modeling, design documentation, and future planning.
7 November 2025
Equinor Awards New ISS Framework Agreements
New ISS agreements ensure operational continuity, local job security, and community benefits at Equinor's Norwegian onshore plants, with a focus on safety and collaboration.
6 November 2025
TA’ZIZ Signs Long‑Term EDC/VCM Export Agreement with Sanmar
Up to 10-year deals to export over 350,000 tpa of EDC and VCM from Ruwais to support PVC plants in Egypt and India; first UAE exports of these chemicals; strengthens UAE-India industrial ties.
6 November 2025
Boehringer Ingelheim's Apecotrep Reduces Proteinuria in Phase II Kidney Trial
Apecotrep, a TRPC6 inhibitor, showed 40% proteinuria reduction in FSGS patients. Phase III trial recruiting; further Phase II trials planned for other kidney diseases.
6 November 2025
Sasol Develops Methane Rich Gas Solution for South Africa's Post-2028 Gas Supply
Sasol plans to supply Methane Rich Gas from 2028-2030 to bridge South Africa's gas supply gap, pending regulatory approval, while transitioning to LNG for long-term needs.
6 November 2025
PureCycle Technologies Q3 2025 Update
Record production, expanded product portfolio, and increased sales pipeline. Ironton compounding to boost capacity. Thailand project progresses. €40M EU grant application accepted.
6 November 2025
Genmab Reports Q3 2025 Financial Results
Revenue up 21% to $2.66B. Proposed Merus acquisition. FDA priority review for epcoritamab. Rina-S gets Breakthrough Therapy Designation. Operating profit rose to $1.007B.
6 November 2025
Lilly's Eloralintide Shows Promising Weight Loss in Phase 2 Obesity Study
Eloralintide led to significant weight loss and improved cardiometabolic factors in a Phase 2 trial, prompting Phase 3 studies for obesity treatment.
6 November 2025
Sasol Develops Methane Rich Gas Solution for South Africa's Post-2028 Gas Supply
Sasol plans to supply Methane Rich Gas from 2028-2030 to bridge the gas supply gap, pending regulatory approval, while transitioning to LNG for long-term needs.
6 November 2025
Heidelberg Materials Reports Q3 Growth, Confirms 2025 Outlook
Q3 results up 5%, operating margin at 25.9%. Transformation Accelerator boosts savings. CCS projects advance, with evoZero cement deliveries starting. 2025 outlook remains positive.
5 November 2025
TA’ZIZ awards $1.99bn EPC for world-scale PVC complex
Ruwais PVC complex will produce 1.9 mtpa PVC, VCM, EDC and caustic soda, due Q4 2028. Part of 4.7 mtpa Phase 1 hub, projected to add $50bn to UAE GDP and 26,000 lifetime jobs.
5 November 2025
Sasol Italy and GreenYellow Italia start construction of 5.1 MWp PV plant in Terranova dei Passerini
On-site PPA project on company land; commissioning H2 2026. Output ~7.61 GWh/yr, avoiding >4,000 tCO2/yr (≈2,800 households).
5 November 2025
Novo Nordisk's Wegovy® Helps Users Meet Health Targets, Reducing Obesity Risks
Wegovy® users achieved BMI and waist targets, improving cardiovascular health and reducing obesity-related risks, as shown in the STEP UP trial.
5 November 2025
Novo Nordisk Reports 12% Sales Growth in DKK, 15% at CER, and R&D Advances in First Nine Months of 2025
Operating profit rose 5% in DKK, 10% at CER. Obesity care sales up 37%. FDA approved Wegovy® for MASH. Novo Nordisk to acquire Akero Therapeutics. Full-year sales growth forecast at 8-11% CER.
5 November 2025
Novo Nordisk Unveils New Oral Semaglutide Analyses at ObesityWeek 2025
Oral semaglutide 25 mg shows improved blood sugar control, cardiovascular risk factors, and weight loss efficacy, comparable to injectable form, across various patient groups.
5 November 2025
BASF Begins Production at Zhanjiang Verbund Site
Production starts at Zhanjiang Verbund site, enhancing BASF's capacity to meet Asia's market demand, with full core completion by 2025, supporting sustainable growth and local production strategy.
4 November 2025
Holcim Secures EU Funding for Romania's First CCS Cement Project
The project will produce 2 million tons of near-zero cement annually from 2032, using CCS technology, boosting sustainable growth and creating jobs in Romania.
4 November 2025
ADNOC and Shell Sign 15-Year LNG Supply Deal for Ruwais Project
ADNOC secures over 80% of Ruwais LNG's capacity in 16 months, with operations set for Q4 2028. The project will use clean power and AI to enhance efficiency and reduce emissions.
4 November 2025
UPM Energy Activates Ultracapacitor at Kuusankoski Plant
The ultracapacitor enhances grid stability by providing rapid, maintenance-free energy storage, crucial for balancing renewable energy fluctuations.
4 November 2025
BP Q3 2025 Financial Results
Q3 saw $7.8bn cash flow, $2.2bn RC profit. Upstream reliability at 96.8%, refining at 96.6%. $4bn+ divestments expected, $14.5bn capex on track. Net debt stable at $26.1bn.
← Previous
Next →
